Magnetic seizure therapy and electroconvulsive therapy increase aperiodic activity

Area of Science:

• Neuroscience
• Psychiatry
• Computational Neuroscience

Background:

• Major depressive disorder (MDD) is a significant global health burden and cause of disability.
• Electroconvulsive therapy (ECT) is a highly effective treatment for treatment-resistant MDD.
• Magnetic seizure therapy (MST) offers a potentially safer alternative to ECT for MDD.

Purpose of the Study:

• To investigate the neural mechanisms underlying the therapeutic effects of ECT and MST.
• To examine the role of aperiodic neural activity, a measure of neural inhibition, in response to ECT and MST.

Main Methods:

• Analyzed electroencephalogram (EEG) data from patients undergoing either ECT or MST.
• Quantified changes in aperiodic neural activity before and after treatment.
• Correlated changes in aperiodic activity with neural inhibition and clinical outcomes.

Main Results:

• Both ECT and MST treatments led to a significant increase in aperiodic neural activity.
• Increased aperiodic activity was associated with greater neural inhibition.
• The study did not find a direct correlation between increased aperiodic activity and clinical efficacy in this cohort.

Conclusions:

• Aperiodic neural activity is a shared neurophysiological marker for both ECT and MST.
• Increased aperiodic activity suggests a common neural mechanism involving neural inhibition for these depression treatments.
• Further research is needed to fully elucidate the relationship between aperiodic activity, neural inhibition, and clinical outcomes in MDD.